BTK and head and neck squamous cell carcinoma: First discovered in HNSCC patients, the ADO-producing CD39+CD73+ Breg cells suppress the activity of effector B cells by inhibiting Bruton’s tyrosine kinase (BTK) phosphorylation and Ca2+ influx (22).